期刊文献+

大肠癌细胞中八聚体结合转录因子4与人类白细胞分化抗原133的表达及相关性 被引量:1

Expressions of Octamer Binding Transcription Factor 4 and Human Leukocyte Differentiation Antigen 133 in Colon Cancer Cells and Their Correlation
下载PDF
导出
摘要 目的探讨大肠癌细胞中人类白细胞分化抗原133(CD133)与八聚体结合转录因子4(OCT4)的表达情况及其相关性。方法采用磁珠细胞分离技术分选出人结肠癌细胞系的CD133+细胞和CD133-细胞,检测两种细胞中OCT4的表达。分别改变CD133+和CD133-细胞中OCT4的表达,观察其对CD133的表达的影响。采用肿瘤球形成实验检验肿瘤细胞干性生物学行为的改变。结果 CD133+细胞中OCT4呈现高表达,CD133-细胞中OCT4基本无表达。CD133+细胞对5-氟尿嘧啶(5-FU)高度抵抗,并且更容易在无血清培养基中形成肿瘤球。干扰OCT4的表达可以降低CD133+细胞中CD133的表达水平,增加对5-FU的敏感性,并且减少肿瘤球形成能力。过表达OCT4增加CD133-细胞CD133的表达水平,降低对5-FU的敏感性,并且减少肿瘤球形成能力。结论 OCT4与CD133在大肠癌细胞中均有表达,OCT4对CD133有直接调控作用。 Objective To explore the expressions of human leukocyte differentiation antigen 133( CD133)and octamer binding transcription factor 4( OCT4) in colon cancer cells and their correlation. Methods CD133+cells and CD133-cells were separated by immunomagnetic separation technology. Their OCT4 expressions were detected and changed,and the effect of OCT4 expressions on CD133 expression was observed. Tumor sphere formation assay was employed to test the cancer stem cell phenotype. Results CD133+cells showed a high expression of OCT4,and CD133-cells showed no expression of OCT4. CD133+cells were of high resistance to 5-fluorouracil( 5-FU),and were easier to form spheres in the serum-free medium. Inhibiting the OCT4 expression reduced the CD133 expression in CD133+cells,increased the 5-FU sensitivity,and reduced the tumor sphere formation ability. Over-expression of OCT4 increased CD133 expression in CD133- cells,decreased 5-FU resistance,and reduced tumor sphere formation ability.Conclusion Both OCT4 and CD133 are expressed in colon cancer cells,OCT4 may play a role on regulating CD133 directly.
出处 《广西医学》 CAS 2014年第7期865-868,共4页 Guangxi Medical Journal
基金 广东省医学科研基金(A2011284)
关键词 大肠癌 八聚体结合转录因子4 人类白细胞分化抗原133 Colon Cancer Octamer binding transcription factor 4 Human leukocyte differentiation antigen 133
  • 相关文献

参考文献15

  • 1Dick JE. Stem cell concepts renew cancer research [ J ]. Blood,2008,112(13) :4 793 - 4 807.
  • 2Bauer N,Fonseea AV, Florek M, et al. New insights into the cell biology of hematopoietic progenitors by studying promi- nin-1 ( CD133 ) [ J ]. Cell Tissue Organs, 2008,188 ( 1 - 2 ) : 127 - 138.
  • 3Singh SK,I-Iawkins C,Clarke ID,et al. Identification of human brain tumor initiating cells[ J]. Nature,2004,432(7 015 ) : 369 - 401.
  • 4Quintana E, Shackleton M, Sabel MS, et al. Efficient tumour formation by single human melanoma cells [ J ]. Nature, 2008,456 ( 7 222 ) :593 - 598.
  • 5Soltysova A, Altanerova V, Altanner C. Cancer stein cells [ J ]. Neoplasma,2005,52 (6) :435 - 440.
  • 6Dalerba P, Dylla S J, Park IK, et al. Phenotypic characteriza- tion of human coloreetal caneer stem cells [ J ]. Proc Natl Acad Sei USA,2007,11M(24) :I0 158 -10 163.
  • 7Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic caneer stem cells [ J ]. Cancer Res, 2007, 67 ( 3 ) : 1 030-1037.
  • 8Rieci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells [ J ]. Nature,2007,445(7 123) :111 - 115.
  • 9Kemper K, Sprick MR, de Bree M, et al. The AC133 epitope,but not the CD133 protein,is lost upon cancer stem cell differentiation [ J ]. Cancer Res, 2010, 70 ( 2 ) : 719 -729.
  • 10Chiba T, Zheng YW, Kita K, et al. Enhanced self-renewal capability in hepatic stem/progenitor cells drives cancer initiation[ J ]. Gastroente,ology ,2007,133 (3) :937 - 950.

二级参考文献28

  • 1邓艳红,兰平.综合治疗对中低位直肠癌功能保护的意义[J].中华胃肠外科杂志,2007,10(4):396-398. 被引量:4
  • 2Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [ J ]. N Engl J Med, 2004, 350(23) : 2335 -2342.
  • 3Ricci- Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human coloncancer - initiating cells[J]. Nature, 2007, 445(123) : 111 - 115.
  • 4Lin E, Jiang Y, Deng Y, et al. Cancer stem cells, endothelial progenitors, and mesenchymal stem cells: "seed and soil" theory revisited[J]. GCR, 2008, 2(4) : 169 - 174.
  • 5Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006[J]. CA Cancer J Clin, 2006, 56(2): 106-130.
  • 6Hirai I, Kimura W, Fuse A, et al. Surgical management for metastatic liver[ J ]. Hepatogastroenterology, 2006, 53 (71) : 757 -763.
  • 7Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment[J]. J Pathol, 2008, 214(1): 3 -9.
  • 8Hombach - Klonisch S, Panigrahi S, Rashedi I, et al. Adult stem cells and their trans - differentiation potential perspectives and therapeutic applications [ J ]. J Mol Med, 2008, 86(12) : 1301 -1314.
  • 9Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response[J]. Nature, 2006, 444(7120) : 756 - 760.
  • 10Woodward WA, Chen MS, Behbod F, et al. WNT/beta - catenin mediates radiation resistance of mouse mammary progenitor eells[J]. Proc Natl Acad Sci USA, 2007, 104 (2), 618-623.

共引文献29

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部